Aesica is a leading supplier of the active ingredient flurbiprofen and the modified S+flurbiprofen, and has supplied the product into the Japanese market for many years. Demand for the new formulation is expected to grow steadily from 2016.
To find out more information,contact enquiries@aesica-pharma.com